• Skip to main content
  • Skip to footer

Oklahoma Medical Research Foundation | OMRF

  • About
    • General Information
    • Disease Research
    • Training & Outreach
    • Events
    • Careers
    • Contact Us
  • Science
    • Scientist Directory
    • Research Programs
    • Research Centers
    • Core Facilities
    • Scientific Publications
    • Scientific Seminars
    • Technology Ventures
  • News
    • Media Resources
    • News Releases
    • Publications
    • On Your Health
    • Bodywork
  • Patients
    • Anti Aging Study
    • Lupus (SLE)
    • MBTPS1 Related Disorders
    • Multiple Sclerosis
    • Rheumatoid Arthritis
    • Sarcoidosis
    • Sjögren’s Disease
    • Osteoarthritis
    • Other Autoimmune Disorders
  • Donate
    • Donate Now
    • Ways to Give
    • Tax Credit
    • Planned Giving
    • Contact Philanthropy
Home - OMRF News - Archives for FDA

FDA

FDA grants designations for OMRF brain tumor drug

September 2, 2020

The Oklahoma Medical Research Foundation is one step closer to beating rare forms of brain cancers.

Filed Under: Videos Tagged With: brain cancer, drug, FDA, kfor, OKN-007, Rheal, scientist-news, Towner

OMRF brain tumor drug receives rare disease designations from the FDA

September 2, 2020

The drug treats fast-growing, deadly brain cancers with no effective treatment.

Filed Under: News, Technology Ventures News Tagged With: 007, administration, approval, bob, Bob Floyd, brain cancer, cancer, center, childhood, diffuse intrinsic pontine glioma, dipg, drug, FDA, Floyd, glioblastoma, glioma, Oblato, Oklahoma Medical Research Foundation, okn, OKN-007, OKN007, OMRF, OUHSC, pediatric, rare pediatric disease designation, Rheal, robert, rpdd, scientist-news, stephenson, Towner

OU, OMRF file for FDA authorization for COVID-19 detection test utilizing Fluidigm technology

April 23, 2020

The test is intended for large-scale testing of patients, with the capacity to test 180,000 samples over the next 90 days.

Filed Under: COVID-19 News, News Tagged With: approval, biomark, biotechnology, coronavirus, covid-19, covid19, drug, emergency, FDA, fluidigm, guthridge, harroz, health sciences center, James, Joel, Judith, Oklahoma, Oklahoma Medical Research Foundation, OMRF, ou, ou medicine, OUHSC, Prescott, samples, scientist-news, site, stephen, testing, university

Bodywork: If a COVID-19 test isn’t FDA approved, can I trust it?

April 21, 2020

Can I trust Covid-19 tests that aren’t FDA approved?

Filed Under: Bodywork, COVID-19 News Tagged With: bodywork, coronavirus, covid-19, covid19, FDA, Prescott, stephen, steve

Existing drug could work against coronavirus

March 16, 2020

The drug, chloroquine phosphate, was originally developed to fight malaria.

Filed Under: News Tagged With: CDC, chloroquine phosphate, corona, coronavirus, covid-19, covid19, doctors, epidemic, FDA, James, Judith, malaria, malarial, medication, news, newsok, OKC, Oklahoma, Oklahoma Medical Research Foundation, oklahoman, OMRF, Pandemic, Prescott, scientist-news, scientists, stephen, steve, virus

Protecting yourself from coronavirus

March 5, 2020

The coronavirus may be new, but the most effective means of prevention are not.

Filed Under: News Tagged With: corona, coronavirus, covid-19, Dr. P, Dr. Prescott, epidemic, FDA, flu symptoms, James, Judith, Outbreak, Pandemic, Prescott, protect, scientist-news, therapy, treatment, virus, yourself

  • « Go to Previous Page
  • Page 1
  • Page 2
  • Page 3
  • Page 4
  • Page 5
  • Go to Next Page »

Before Footer

Equal Opportunity Employer

Footer

  • Jobs
  • Directory
  • Donor Privacy Statement
  • Ethics Point
  • Intranet
Facebook Twitter Instagram Linkedin

Subscribe to OMRF News
  • Contact
  • Careers
  • Donor Privacy
  • Ethics Point
  • Intranet
OMRF Logo
OKLAHOMA MEDICAL RESEARCH FOUNDATION
825 NE 13th St.
Oklahoma City, OK 73104
(405) 271-6673
Charity navigatorUnited WayTop Workplace